Education
About Us
Working with TipRanks
Follow Us
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
Viridian Therapeutics (VRDN) Ownership Overview
4.27% Insiders
28.06% Mutual Funds
1.28% Other Institutional Investors
12.93% ETFs
53.46% Public Companies and
Individual Investors
The ownership structure of Viridian Therapeutics (VRDN) stock is a mix of institutional, retail, and individual investors. Approximately 42.27% of the company’s stock is owned by Institutional Investors, 4.27% is owned by Insiders, and 53.46% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2025 | xxxxxxxxxxxxx | $184983 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $771640 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $5268307 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $6256147 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,580,273 | Institution | 4.38% | 82,382,082 | |
| 3,494,113 | Institution | 4.28% | 80,399,540 | |
| 3,459,913 | Institution | 4.24% | 79,612,598 | |
| 3,459,913 | Insider | 4.24% | 79,612,598 | |
| 3,368,979 | Institution | 4.13% | 77,520,207 | |
| 3,328,064 | Institution | 4.08% | 76,578,753 | |
| 2,819,711 | Institution | 3.45% | 64,881,550 | |
| 2,268,357 | Institution | 2.78% | 52,194,895 | |
| 2,257,010 | Institution | 2.76% | 51,933,800 | |
| 1,838,886 | Institution | 2.25% | 42,312,767 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,494,113 | Institution | 4.28% | 80,399,540 | |
| 3,368,979 | Institution | 4.13% | 77,520,207 | |
| 3,328,064 | Institution | 4.08% | 76,578,753 | |
| 2,268,357 | Institution | 2.78% | 52,194,895 | |
| 1,209,740 | Institution | 1.48% | 27,836,117 | |
| 1,148,865 | Institution | 1.41% | 26,435,384 | |
| 869,988 | Institution | 1.07% | 20,018,424 | |
| 765,800 | Institution | 0.94% | 17,621,058 | |
| 752,813 | Institution | 0.92% | 17,322,227 | |
| 663,927 | Institution | 0.81% | 15,276,960 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,237,230 | Institution | 2.74% | 48,279,423 | |
| 1,663,518 | Institution | 2.04% | 38,277,549 | |
| 953,314 | Institution | 1.17% | 21,230,303 | |
| 777,550 | Institution | 0.95% | 16,779,529 | |
| 488,582 | Institution | 0.60% | 11,242,272 | |
| 347,035 | Institution | 0.42% | 7,728,469 | |
| 334,285 | Institution | 0.41% | 7,213,870 | |
| 168,598 | Institution | 0.21% | 3,638,345 | |
| 163,410 | Institution | 0.20% | 3,760,064 | |
| 123,959 | Institution | 0.15% | 2,852,297 |
FAQ
Who Owns Viridian Therapeutics (VRDN)?
According to the latest TipRanks data, approximately 1.28% of the company's stock is held by institutional investors, 4.27% is held by insiders, and 53.46% is held by retail investors.
What percentage of Viridian Therapeutics (VRDN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.28% of Viridian Therapeutics (VRDN) stock is held by institutional investors.
What percentage of Viridian Therapeutics (VRDN) stock is held by retail investors?
According to the latest TipRanks data, approximately 53.46% of Viridian Therapeutics (VRDN) stock is held by retail investors.
Who owns the most shares of Viridian Therapeutics (VRDN)?
Vanguard owns the most shares of Viridian Therapeutics (VRDN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.